DFTX

NASD Definium Therapeutics, Inc.
Oct 7, 2026 · 5:31 AM ET LAST TRADE Market Closed

$35.45 ↓ -0.17 (-0.48%) Trading Down from the previous close of $35.62

YTD change
+130.49%
vs 20-day SMA
-6.55%
vs 200-day SMA
N/A

Price ranges

Previous day
$34.38 $36.55
open $36.55 close $35.62
-$0.93 (-2.54%)
Today
$0.00 $0.00
$35.45
Past week
$34.38 $38.95
from $38.21 now $35.45
-$2.76 (-7.22%)
Past month
$34.38 $43.77
from $38.23 now $35.45
-$2.78 (-7.27%)
This year
$14.62 $49.70
from $15.38 now $35.45
+$20.07 (+130.49%)

Price & Performance

+15.04 (+73.08%) / 6M

$17.75$28.74$39.73$50.72Apr 7Jul 8Oct 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 28.7% away from all-time highs of $49.70
  • DFTX is up 130% since the beginning of the year
  • DFTX is up 130% over the past 12 months
  • DFTX is down 7% over the past 1 month
  • 9% of all DFTX investors are betting against DFTX

DFTX reads not so good: the 12-month move is +131.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.44
Earnings momentum -156.9% Quarterly EPS growth
Quarterly change -156.9%

Valuation

P/E ratio N/A
Enterprise value $3.0B
Beta 1.51

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$1.1B
Debt$36.5K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $4.8B

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $402.60 -0.09%
MRNA Moderna, Inc. $187.46 -7.75%
RVMD Revolution Medicines, Inc. $199.87 -3.76%
ROIV Roivant Sciences Ltd. $35.53 -0.70%
BNTX BioNTech SE Sponsored ADR $95.73 -1.96%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.